Viveve Medical, Inc. (VIVE)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jul 31, 2025, 9:30 AM EDT
Accolade Market Cap
Viveve Medical has a market cap or net worth of $1.07 thousand as of August 1, 2025. Its market cap has decreased by -90.91% in one year.
Market Cap
1.07K
Enterprise Value
n/a
Revenue
6.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since June 27, 2013, Viveve Medical's market cap has decreased from 508.17B to 1.07K, a decrease of -100.00%. That is a compound annual growth rate of -80.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 1.07K | -50.02% |
| Dec 31, 2024 | 2.15K | - |
| Dec 29, 2023 | 2.15K | -99.95% |
| Dec 30, 2022 | 4.56M | -62.29% |
| Dec 31, 2021 | 12.09M | 18.44% |
| Dec 31, 2020 | 10.21M | 101.30% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.76B |
| Veradigm | 794.80M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 563.22M |
| Glass House Brands | 409.73M |
| Nika Pharmaceuticals | 366.89M |
| CytoDyn | 357.98M |
| Northwest Biotherapeutics | 351.67M |